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Abstract
 
The coordinated migration and maturation of dendritic cells (DCs) such as intraepithelial Langer-
hans cells (LCs) is considered critical for T cell priming in response to inflammation in the periph-
ery. However, little is known about the role of inflammatory mediators for LC maturation and
recruitment to lymph nodes in vivo. Here we show in human dermatopathic lymphadenitis
(DL), which features an expanded population of LCs in one draining lymph node associated with
inflammatory lesions in its tributary skin area, that the Langerin/CD207
 
 
 
 LCs constitute a pre-
dominant population of immature DCs, which express CD1a, and CD68, but not CD83, CD86,
and DC–lysosomal-associated membrane protein (LAMP)/CD208. Using LC-type cells gener-
ated in vitro in the presence of transforming growth factor (TGF)-
 
 
 
1, we further found that tu-
mor necrosis factor (TNF)-
 
 
 
, as a prototype proinflammatory factor, and a variety of inflamma-
tory stimuli and bacterial products, increase Langerin expression and Langerin dependent Birbeck
granules formation in cell which nevertheless lack costimulatory molecules, DC–LAMP/CD208
and potent T cell stimulatory activity but express CCR7 and respond to the lymph node homing
chemokines CCL19 and CCL21. This indicates that LC migration and maturation can be inde-
pendently regulated events. We suggest that during DL, inflammatory stimuli in the skin increase
the migration of LCs to the lymph node but without associated maturation. Immature LCs might
regulate immune responses during chronic inflammation.
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Introduction
 
Dendritic cells (DCs)
 
*
 
 sample antigen in the periphery,
where they are present in an immature state as illustrated by
Langerhans cells (LCs) in the skin, mucosae and in the lung,
and migrate to lymphoid organs where mature DCs present
antigen to T cells and can initiate immune responses (1, 2).
Full activation by DCs of an antigen-specific T cell into an
effector cell requires the expression of costimulatory mole-
cules by DCs and the accumulation of MHC class II com-
plexes, achieved during a complex process referred to as DC
maturation (references 3 and 4, for reviews, see references 1
and 2). Migration to the lymph nodes and maturation of
DCs are therefore crucial steps in the initiation of specific
immune responses (1, 2). DC maturation has been character-
ized mostly in DCs cultured in vitro and may be induced by
numerous inflammatory stimuli including the disruption of
the epidermis (5, 6), proinflammatory cytokines (e.g.,
TNF-
 
 
 
 and IL-1) (3, 4, 7, 8), necrotic cells (9, 10), and
pathogen products including bacterial components (3, 4, 8).
DC maturation has also been shown to result in vitro and in
vivo from cognate CD4
 
 
 
 T cell help mediated by CD40L
(11–15). The migration of DCs from the periphery to drain-
ing lymph nodes involves inflammatory stimuli and cyto-
kines (e.g., TNF-
 
 
 
 and IL-1) that result most notably in spe-
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cific changes in chemokine receptor expression as well as in
DC chemokine responsiveness (16–20). Those steps are co-
ordinated in a number of models and DC migration fre-
quently appears to result from exposure to the same stimuli
as DC maturation. The role of inflammatory stimuli in the
maturation of DCs needs however to be further investigated
in vivo. Two major issues must be considered. First, many
previous experiments have involved DC purification ex
vivo, or culture in vitro, or in vivo perturbations that may al-
ter DC maturation and function. A second issue is that im-
mature DCs does not represent an homogenous population
in vivo or in vitro (1, 2) and the maturation of different sub-
sets may require distinct stimuli (21). This is important as
mature DCs induce immunity, whereas the persistence of an
immature phenotype could lead to a state of tolerance, e.g.,
due to the lack of costimulatory molecules (22–26).
As an in vivo model of DC mobilization with the LC
phenotype, we chose to study dermatopathic lymphadenitis
(DL), a reactive condition that features the enlargement of
(usually) one draining LNs in reaction to inflammatory le-
sions in its tributary skin area (27–31). DL may be associated
with a variety of skin disorders (31). Histologically, the en-
larged LNs display a marked expansion of the paracortex, in-
cluding pale-staining large cells identified as LCs on the basis
of their morphology, their expression of CD1a, and the
presence of Birbeck granules (BGs; references 28–30). The
accumulation of BG-containing cells in draining LNs has
also been observed following experimental skin lesion in
rabbits (32). DL is thought to involve immigration of LCs
from the skin because (a) the affected lymph nodes drain a
site of skin disease, (b) because LCs can be observed in the
afferent sinuses of the affected lymph nodes, and (c) such
cells frequently contain melanin, which is likely to be trans-
ported from the skin in a TGF-
 
 
 
–dependent, LC-dependent
manner (33). Nevertheless there is still no direct, formal
proof that the LN LCs in DL derive from the epidermis
rather than from other precursors.
In basal conditions, LCs are immature DCs (5, 6, 34), lo-
cated above the basal layer of epithelial cells in the skin, oral,
nasal, esophageal, pulmonary, vaginal, and rectal mucosae.
LCs specifically express E-cadherin, CD1a, and the lectin Lan-
gerin/CD207, an endocytic receptor that induces BG forma-
tion (35, 36). Their emigration from the skin to the lymph
node via afferent lymphatics has been well documented (1, 2,
29, 34) and the current paradigm of DC migration and matu-
ration actually originates from observations on LCs.
In this study, we found that LCs present in T cell areas of
skin-draining LNs of DL patients were largely immature, in-
dicating that recruitment to the lymph node and maturation
of LCs can be independently regulated events and question-
ing the role of inflammatory mediators in the maturation of
LCs in vivo. In vitro–generated LCs further indicated that in
the presence of TGF-
 
 
 
1, TNF-
 
 
 
, and other inflammatory
stimuli-favored the maintenance of an immature phenotype
in spite of the acquisition of CCR7 expression and respon-
siveness to LN homing chemokines. Altogether, our results
suggest that immature LCs may play a role in secondary lym-
phoid organs during chronic inflammation.
 
Materials and Methods
 
Antibodies, Media, and Cytokine.
 
FITC-conjugated CD1a (clone
BL1, mouse IgG1), MHC class I (MHC ABC, mouse IgG2a),
MHC class II (DR, mouse IgG2), and CD83 (mouse IgG2b)
were obtained from Immunotech. Uncoupled DC-LAMP/
CD208 (104.G4, mouse IgG1), CD80 (mouse IgG1), and CD40
(mouse IgG1) were also purchased from Immunotech. PE-conju-
gated CD14 (Leu-M3, mouse IgG2b), CD1a, and CD86 (mouse
IgG2b) were obtained from Becton Dickinson. mAb DCGM4
(mouse IgG1) to Langerin/CD207 has been described previously
(36). Uncoupled anti–E-cadherin (HECD-1, mouse IgG1) was
obtained from R&D Systems. Anti-CCR7 (clone 2H4 mouse
IgM) was obtained from Becton Dickinson. The medium used
for cell culture experiments (complete medium) was RPMI 1640
(GIBCO BRL) supplemented with 2 mM 
 
L
 
-glutamine, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 10% heat-inacti-
vated FCS Myoclone (all from GIBCO BRL). Recombinant
human GM-CSF was provided by Sandoz AG. Recombinant
human IL-4, TGF-
 
 
 
1, TNF-
 
 
 
, IL-1
 
 
 
, LARC, ELC, and SLC
were all purchased from R&D Systems. LPS from 
 
Escherichia
coli
 
 0127-B8 and 026-B6 were purchased from Sigma-Aldrich.
Lysine fixable FITC-dextran, MW 
 
 
 
 40,000 and heat-inacti-
vated 
 
E. coli 
 
(K12) conjugated to Texas-red were purchased from
Molecular Probes. BCG–GFP was a gift from C. Locht, IN-
SERM, Institut Pasteur de Lille, Lille, France (37). Murine
fibroblast cell lines transfected with human CD40L (LcCD40L)
or CD32 (LcCD32) were provided by F. Brière (Schering-
Plough; reference 38). Tetanus toxoid was a gift of F. Le Deist
(Laboratoire d’Immunologie Clinique, Hopital Necker, Paris,
France).
 
Patients.
 
Fixed and frozen samples from lymph nodes re-
moved for diagnostic purpose were retrieved from the files of the
Necker-Enfants Malades and Henri Mondor Hopitals, Paris,
France. DL is the reactive condition that realizes the enlargement
of (usually) one draining LNs in reaction to inflammatory lesions
in its tributary skin area (31). Diagnosis of dermatopathic lym-
phadenopathy was established at Necker-Enfants Malades and
Henri Mondor Hopitals as the presence of a marked expansion of
the paracortex by pale-staining histiocytic cells expressing CD1a,
occasionally containing melanin, with the preservation of the B
cell follicles and the absence of other specific lesion (31). The
presence of a skin lesion in the tributary skin area of the involved
LNs was documented in all the cases included in the study. Char-
acteristics of the patients with DL are summarized in Table I.
 
Immunohistochemistry and Immunofluorescence on Tissue Sections.
 
Immunohistochemical analysis of frozen lymph node 5 
 
 
 
m-thin
section fixed in acetone was done after the streptavidin-biotin
immunoperoxidase technique as described previously (21, 39).
Double staining was performed according to published proce-
dures (40). Fast Blue (Sigma-Aldrich) and AEC (Sigma-Aldrich)
were used as substrates for alkaline phosphatase and peroxidase,
respectively. For confocal microscopy, slides were rehydrated for
5 min in PBS with 2% pooled normal human AB serum (staining
medium), and then incubated for 1 h at room temperature with
mouse anti–DC-LAMP, anti-CD83, or anti-Langerin followed
by goat anti–mouse Cy5, FITC-conjugated mAb to Langerin and
to HLA-DR, PE-conjugated mAb to CD1a, CD14, CD86, and
CD68. Slides were mounted with Fluoprep (Biomerieux SA,
Marcy l’Etoile, France) and analyzed with a confocal laser system
(LSM 510; Zeiss Laboratory).
 
In Vitro Culture of LC-type Cells.
 
DCs differentiated from mono-
cytes were cultured as described previously (21, 41) with the
following modifications. Cells were cultured in complete me- 
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dium supplemented at day 0 with 100 ng/ml GM-CSF, 10 ng/ml
IL-4, and 10 ng /ml TGF-
 
 
 
1. At days 2 and 4, fresh medium,
supplemented with GM-CSF and TGF-
 
 
 
1 (but not IL-4) was
added. At days 5–7 of culture, cells were resuspended in 24-well
tissue culture plates at a concentration of 5.10
 
5
 
 cell/ml in com-
plete medium supplemented with the above-mentioned cyto-
kines. Cells were then stimulated for 40 h with TNF-
 
 
 
, IL-1
 
 
 
,
LPS, Texas-red–conjugated
 
 E. coli 
 
(Bioparticles; Molecular
Probes) or BCG-GFP, at various doses or kept in medium alone.
For analysis of CD40L-mediated activation, fibroblastic L-cells
transfected with either CD40L (LcCD40L), or CD32 (LcCD32),
as control, were irradiated at 80 Gy and added to the culture wells
in a ratio of 2/10. BGG-GFP was grown in liquid culture at 37
 
 
 
C
in Stauton medium containing 25 
 
 
 
g/ml of kanamycin, using
stationary tissue culture flask. For infection experiment, fresh bac-
teria were collected at the end of the exponential phase (10E9
CFU/ml), centrifuged at 5,000 
 
g
 
 for 30 min at 4
 
 
 
C, and washed
twice with LPS-free RPMI 1640 (GIBCO BRL). Pellets were
then suspended in RPMI 1640 without antibiotics to the appro-
priate dilution in order to obtain the required multiplicity of in-
fection. BCG-GFP was cocultured with LC-type cells for up to
36 h at a multiplicity of infection of 20:1 to 50:1.
 
Flow Cytometry and Confocal Microscopy Analysis of Cell Suspen-
sions.
 
3.10
 
5
 
 cells per point were incubated in 96-well plates
(Becton Dickinson) for 15 min at 4
 
 
 
C in PBS, 2% human AB se-
rum, and 0.01 M NaN
 
3
 
, with mAbs at the appropriate concentra-
tion, or with control isotype-matched irrelevant mAbs at the same
concentration. After washing, cells were incubated when appro-
priate with F(ab
 
 
 
)
 
2
 
 GAM-FITC or APC (Immunotech) for 15
min at 4
 
 
 
C in the same buffer and washed again. Propidium iodide
was added to each sample before analysis in order to exclude dead
cells. 5.10
 
4
 
 events were analyzed with a FACScalibur™ (Becton
Dickinson) using CELLQuest™ software (Becton Dickinson). For
confocal immunofluorescence microscopy examination we fol-
lowed previously reported protocols (21, 35). In brief, cells were
adhered to glass slides coated with 50 
 
 
 
g/ml poly-
 
L
 
-lysine (Sigma-
Aldrich), fixed in 4% paraformaldehyde in Ca
 
2
 
 
 
/Mg
 
  
 
-free PBS,
and quenched with 0.1 M glycine. Cells were permeabilized in
PBS/saponin (0.01%)/gelatin (0.25%)/NP-40 (0.1%), and sequen-
tially incubated with FITC-conjugated mAb to Langerin or HLA
DR, PE-conjugated mAb to CD68 and CD86, and unconjugated
mAb to Langerin or DC–LAMP, revealed by anti–mouse-Cy5
(Jackson ImmunoResearch Laboratories). Mounted slides were
analyzed with either confocal laser microscope systems at our dis-
posal (Zeiss LSM 510, and CLSM SP1).
 
Chemotaxis Assay. 
 
Cell migration was evaluated using a che-
motaxis microchamber technique (48-well Boyden microcham-
ber; Neuroprobe) as described previously (16). In brief, human
recombinant MIP-3
 
 
 
/LARC/CCL20 was diluted to 500 ng/ml,
MIP-3
 
 
 
/ELC/CCL19 and 6Ckine/SLC/CCL21 were diluted
to 100 ng/ml, respectively. Diluted chemokines were added to
the bottom wells and 10
 
5
 
 cells per well were applied to the top
wells of the chamber, with a standard 5-
 
 
 
m pore polycarbonate
filter (Neuroprobe) separating the bottom wells. After 1 h and 15
 
Table I.
 
Patients with Dermatopathic Lymphadenitis
 
Age/Sex Diagnosis (Skin) Skin lesions Biopsied LN Time between onset of skin lesions and LN biopsy
25/F Scabies Back Spinal 1 mo
57/M Nummular dermatitis Arms Axillary
 
 
 
1 mo
54/M Eczema-like Localized, thorax Cervical G
 
 
 
1 mo
45/M Eczema Generalized Cervical D Unknown
33/M Urticaria Generalized Axillary 3 wk
29/M Acne Arms and face Axillary
 
 
 
1 mo
45/M Hidrosadenitis Axillary Axillary
 
 
 
1 mo
24/F
T cell lymphoma
(Mycosis Fungoides) Arm Axillary Unknown
14/M
T cell lymphoma
(Mycosis Fungoides) Arms, shoulders Axillary 1 y
20/M
T cell lymphoma
(Mycosis Fungoides) Arms, shoulders Axillary 1 y
55/M
T cell lymphoma
(Mycosis Fungoides) Arm, face Axillary unknown (
 
 
 
1 y)
40/M Skin B cell lymphoma Arms, shoulders Axillary
 
 
 
1 mo 
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min of incubation at 37
 
 
 
C, cells that had migrated to the under-
side of the filter were stained with Field’s A and Field’s B (BDH,
Dorset, England) and counted in two randomly selected low-
power fields (original magnification: 
 
 
 
20). Each assay was per-
formed in duplicate and the results were expressed as the mean
 
 
 
SD of migrating cells per two fields.
 
Autologous Response to Tetanus Toxin.
 
T cell proliferative re-
sponse to tetanus toxin was evaluated as described previously
(21). In brief, DCs were collected, washed three times, pulsed for
40 h with tetanus toxin or medium alone, with or without TNF-
 
 
 
(10 ng/ml) or LcCD40L. Cells were washed twice in PBS, re-
suspended in RPMI 1640 with 10% human AB serum and added
in triplicate at various concentrations to 10
 
5
 
 autologous T cells
per well in 96-well tissue culture plates (Falcon; Becton Dickin-
son Labware). T cells were isolated by standard Ficoll-Paque
method followed by magnetic depletion of non-T cells (MACS
 
®
 
;
Miltenyi Biotec). 
 
3
 
[H]thymidine (Amersham Life Science) incor-
poration was measured in newly synthesized DNA over 18 h, us-
ing pulses initiated at day 4 or 5 of the culture with 1 
 
 
 
Ci/well of
 
3
 
[H]thymidine. Cells were then harvested with a 96-well Har-
vester (Amersham Pharmacia Biotech), collected on glass-fiber
filter (Amersham Pharmacia Biotech) and the incorporation of
thymidine was measured with a 
 
 
 
-plate micro scintillation
counter (LKB; Amersham Pharmacia Biotech).
Transmission electron microscopy and immunogold labeling.
DCs were fixed with 2% glutaraldehyde in cacodylate buffer. Af-
Figure 1. High numbers of
LCs are recruited in afferent si-
nuses and T cell areas of inflamma-
tory-skin draining LNs. LNs cry-
ostat section (5  m thick) from
patients with DL were stained
the indicated antibodies, repre-
sentative sections are shown. (A,
left) Langerin staining (in red,
original magnification:  100);
(right) Langerin staining (in red)
and anti-CD83 (in blue), original
magnification:    400. Arrow-
heads indicate the peripheral si-
nus. (B) Left and middle, Lan-
gerin, and E-cadherin staining
(in red) on serial sections. Right
CD1a staining, original magnifi-
cation:  100. “f” denotes B cell
follicle. (C) Double immuno-
staining of DL sections using
anti-Langerin (revealed in blue
with alkaline phosphatase) and
anti-CD83 (left), or anti-CD3
(right) (revealed with peroxidase
in brownish). (D) Similar stain-
ing on sections from reactive LN
draining normal skin. 
421
 
Geissmann
 
 
 
et al.
ter rinsing in cacodylate buffer with sucrose for 12 h, the cells
were processed for transmission electron microscopy. Cells were
postfixed with an aqueous solution of 1% osmium tetroxide in
cacodylate buffer with sucrose and embedded in epoxy medium
after dehydration through a graded series of ethanols. Ultrathin
sections were stained with lead citrate and uranyl acetate and ex-
amined with a JEOL 1200EX electron microscope (CMEABG,
Universite de Lyon, France). For Langerin cross-linking and im-
munogold labeling, DC suspension were incubated for 1 h at 4
 
 
 
C
with either DCGM4 mAb at 2 
 
 
 
g/ml in PBS 2% BSA (Sigma-
Aldrich) or with control mouse IgG at the same concentration
and then washed at 4
 
 
 
C and incubated for various time periods
with goat anti–mouse Igs conjugated to 5-nm gold granules (Am-
ersham Pharmacia Biotech). Cells were then washed and pro-
cessed as above.
 
Results
 
LCs Selectively Accumulate in LNs Draining Inflammatory
Skin.
 
To investigate the differentiation state of human
DCs after skin lesions, we examined axillary and cervical
LNs draining pruritic skin from patients with DL (
 
n
 
 
 
  
 
12,
Table I) in comparison with control reactive LNs (RL,
 
n
 
 
 
  
 
10) without history of skin lesion. Patients with DL
presented either eczema (
 
n 
 
  
 
3), acne, hidrosadenitis, ur-
ticaria, or scabies infection (
 
n 
 
  
 
1 each) or cutaneous lym-
phoma (
 
n
 
 
 
  
 
5). Control samples were obtained from pa-
tients without skin lesion and with reactive axillary and
cervical LNs of miscellaneous etiology. Strikingly very
large numbers of cells expressing Langerin (CD207), a
LC-specific lectin (35, 36), were present in the T cells ar-
eas and in the afferent sinuses of all DL LNs (Fig. 1, A–C).
In contrast, Langerin
 
 
 
 cells were very rare or not detect-
able in inflamed peripheral LNs in the absence of skin le-
sions (Fig. 1 D). The Langerin
 
 
 
 cells coexpressed CD1a
(Fig. 1 B, see also Fig. 2 C) and the LC adhesion molecule
E-cadherin, albeit at low levels (Fig. 1 B). Langerin
 
 
 
 
 
cells
were localized in close contact with T cells, as evaluated
by anti-CD3 staining (Fig. 1 C). Altogether, these features
characterize a selective and prominent accumulation of
LCs in DL LNs. These features were similar in all 12 DL
LNs examined. The predominance of Langerin
 
 
 
 cells in
the LN in the presence of skin lesions (Fig. 1, C and D),
their location in the afferent sinuses (Fig. 1 A) and the
presence of Langerin
 
 
 
 cells containing melanin (unpub-
Figure 2. LN Langerin  LCs express CD1  and CD68 but not CD83 DC–LAMP and CD86. (A) LNs cryostat section from patients with DL were
stained with anti-CD83 antibody revealed with Cy5 (blue), FITC-anti-Langerin (green), and PE-anti CD68 (red) and analyzed by confocal microscopy.
Representative sections are shown. Original magnification:  400; (B) triple immunostaining on DL section using FITC-conjugated Langerin (green),
anti-DC–LAMP antibody revealed with Cy5 (blue), and PE-anti CD68 (red) and analyzed by confocal microscopy. Magnification:  100. (C) Double
immunostaining on DL section using FITC anti-CD1a (green) and anti-Langerin revealed with Cy3 (red), and FITC-anti-Langerin (green), and PE-anti
CD86 (red) and analyzed by confocal microscopy. Representative sections are shown. Original magnification:  100. 
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lished data), suggest that these LCs originate from the skin.
Yet, we cannot be exclude that they derive from other,
e.g., circulating, precursors.
LCs in Human LNs that Drain Inflammatory Skin Are in an
Immature State. We further determined the differentia-
tion stage of Langerin  cells within DL LNs. Cells ex-
pressing CD83, a marker of mature DCs, were present
in comparable numbers in the T cell zone of both skin
reactive and control LNs (Fig. 1, C and D); however,
the abundant Langerin  cells appeared to be largely de-
void of CD83 in both the T cell zone and in the afferent
sinuses of DL LN (Fig. 1, A and C), suggesting that the
accumulated LCs are not fully mature DCs. The expres-
sion of CD68 a lysosomal protein expressed in macro-
phages and immature DCs (42), DC–LAMP, a lysosomal
protein restricted to mature DC (43), CD83, MHC class
Figure 3. In vitro differentiation of LC-type cells. (A)
TNF-  upregulates membrane Langerin expression but
not MHC class I, class II, and CD86. Cells were cul-
tured for 5–6 d in the presence of the indicated cyto-
kines as indicated in Materials and Methods. 10 ng/ml IL-4
was added at day 0 only. Cells were analyzed by flow cy-
tometry for membrane expression of HLA-ABC,
HLA-DR, Langerin, and CD1a and CD86. Dot plots
are gated on viable cells. (B) CD40L but not TNF-  in-
duces internalization of Langerin, upregulation of mem-
brane HLA-DR and acquisition of a Mature dendritic
shape. Cells cultured as in A are permeabilized and ana-
lyzed by confocal microscopy for expression of Langerin
(top panel) and DR (bottom panel). Left panels repre-
sent cells cultured for 5–6 d in GM-CSF, IL-4 (added at
day 0 only), and TGF- 1, middle panels represent cells
cultured for 5–6 d in GM-CSF, IL-4 (added at day 0
only), TGF- 1, and TNF-  (10 ng/ml for the last 40 h
of culture). The right panels represent cells cultured for
5–6 d in GM-CSF, IL-4 (added at day 0 only), TGF- 1,
with CD40L transfected fibroblasts (for the last 40h of
culture). Incubation with control fibroblasts (LcCD32)
as described in Materials and Methods does not results in
the activation of cells (unpublished data). Original mag-
nification:   400. (C) TNF-  treated LC-type cells ex-
press CD68 while CD40L treated LC-type cells express
DC-LAMP. Cells cultured and processed as in B were
analyzed for expression of Langerin, DC-LAMP and
CD68 by three-color confocal microscopy. Left panels
represent cells cultured for 5–6 d in GM-CSF, IL-4
(added at day 0 only), TGF- 1 and TNF-  (10 ng/ml
for the last 40 h of culture). Right panels represent cells
cultured for 5–6 d in GM-CSF, IL-4 (added at day 0
only), TGF- 1, with CD40L transfected fibroblasts (for
the last 40 h of culture). Incubation with control fibro-
blasts (LcCD32) as described in Materials and Methods
does not result in the activation of DCs (unpublished
data and reference 26).423 Geissmann et al.
I and II antigens, CD1a, and the costimulatory molecule
CD86 was determined by confocal immunofluorescence
microscopy.
Analysis of triple-stained sections demonstrated that most
Langerin  cells were positive for CD68, but negative for
CD83 and DC–LAMP, whereas CD83  cells were nega-
tive for Langerin and CD68 and positive for DC–LAMP
(Fig. 2, A and B). Consistently, Langerin  cells were
mostly CD1a  and CD86  (Fig. 2 C). Langerin  cells ex-
pressed both class I and II antigens, with a predominant in-
tracellular expression of class II antigens (unpublished data).
These features were similar in all 12 DL LNs examined.
These data demonstrate that LCs recruited in the T cell
area of inflammatory skin draining LNs can have a predom-
inant immature phenotype.
These results also show the coexistence of immature LCs
and mature DCs in inflammatory skin draining LNs.
CD83  dendritic can be observed within the afferent si-
nuses (Fig. 1 A), and are present in inflamed LNs in the ab-
sence of skin lesions (Fig. 1 D), suggesting that the
Langerin , CD68 , CD83  DC–LAMP   CD86  subset
corresponds to immature LCs and the CD83  DC–
LAMP  DC subset correspond to interstitial DCs (DCi)
emigrating from the dermis (44) more likely than to mature
Langerin  LCs. Our results thus suggest that inflammatory
signals could differentially affect the maturation of Langer-
hans and non-Langerhans DCs in vivo.
TNF-  Potentiates Expression of Langerin and Formation of
BGs in Immature Monocyte-derived LC-type Cells. To ex-
plore the effect of inflammatory cytokines on LC differen-
tiation and migration, we cultured LC-type cells in the
presence of TNF- . LCs may be derived from CD34  he-
mopoietic progenitor-cells (45–48). However, these cells
represent a wide range of maturation stages. To synchro-
nize the maturation stages of LCs in the cultures we used
mainly LC-type cells derived from human monocytes,
grown in the presence of GM-CSF, IL-4, and TGF- 1
(21, 41). This further allowed us to compare LCs with
DCi derived from the same monocytes differentiated in
the presence of GM-CSF and IL-4 (7, 21, 49). When cul-
tured in the absence of TNF-  approximately one-third of
the monocyte-derived LC-type cells expressed significant
surface levels of Langerin (Fig. 3 A). Remarkably, the ad-
dition of TNF-  at days 5 or 6 of the culture strongly in-
Figure 4. Cross-linking of Langerin induces the
formation of BGs in TNF-  treated LC-type cells.
(1–3) LC type-cells were cultured in the presence
of GM-CSF, IL-4 (added at day 0 only), TGF- 1
and TNF-  (added at 10 ng/ml for the last 40 h of
culture). Inset (1 and 3) show magnification of BGs.
Bar   100 nm on panels 1 and 3 and 1 p.m. on
panel 2. (4–7) Cells were cultured as for panels 1–3,
and Langerin was cross-linked with mouse anti-
Langerin Ab and gold-labeled goat anti–mouse Ig
for various times. Panel 4 shows the formation of
large numbers of gold labeled BGs and coated pits
after a very short time ( 1 min). Bar   100 nm.
Panels 5–7 show BGs and coated pits at higher
magnification. In the absence of TGF- 1 however,
TNF-  did not induce the expression of Langerin,
nor the formation of BGs (unpublished data). Bar  
100 nm.424 Differentiation of Langerhans Cells in Response to Inflammation
creased the proportion of Langerin  cells (Fig. 3 A).
Langerin  cells increased from 33   12% to 75   15% of
total cells (n   6 independent experiments), with a consid-
erable higher MFI (from 66   20 to 250   130). How-
ever, the presence of TGF- 1 was mandatory for the in-
duction of Langerin and BGs by TNF-  (unpublished
data) demonstrating that TNF-  acts in synergy with
TGF- 1 to promote LC differentiation.
In contrast to the up regulation of Langerin in the vast
majority of the cells, TNF-  treatment increased surface
expression of MHC class II and CD86 molecules only in a
minor proportion of Langerin  cells (Fig. 3 A), in accor-
dance with our previous results (21). While the presence of
TGF- 1 is absolutely required during the first 6 d of cul-
ture to generate LCs, the presence of TGF- 1 contribute
but was dispensable to maintain the immature LC pheno-
type upon addition of proinflammatory signals (21, and un-
published data). Confocal microscopy further confirmed
that TNF-  treated LC-type cells expressed CD68 and in-
tracellular MHC class II but not DC–LAMP (Fig. 3, B and
C). In striking contrast to TNF- , CD40L induced a full
maturation of LC-type cells in vitro, as illustrated by the
strong upregulation of MHC class II and CD86 (Fig. 3, A
and B), the loss of CD68 and the induction of DC–LAMP
(Fig. 3 C). Although CD40L stimulation resulted in the
translocation of class II molecules to the cell surface and the
loss of surface Langerin expression, Langerin remained de-
tectable within intracellular compartments for at least 48 h
(Fig. 3 B).
Electron microscopy confirmed that TNF- –treated
cells have typical LC features as demonstrated by the pres-
ence of BGs (Fig. 4, panels 1–3). To assess whether Lan-
gerin is functional in TNF- –treated cells, we monitored
the formation of BGs after Langerin cross-linking. LC-type
cells exposed to mouse anti-Langerin Ab and gold-labeled
goat anti–mouse Ig developed very rapidly ( 1 min) high
numbers of gold-labeled BGs (Fig. 4, panels 4–7). These
data further emphasize that TNF-  induces LCs to express
functional Langerin in conjunction with TGF- 1.
TNF-  Induces Functionally Immature LCs, which Express
CCR7 and Respond to LN Homing Chemokines. Next, we
investigated other functional properties of LC-type cells acti-
vated by TNF-  such as their Ag presentation capacity and
their ability to migrate toward the LN environment. First, in
accordance with our previous results (21) we found that
treatment with TNF-  did not enable LC-type cells to stim-
ulate the proliferation of autologous antigen specific memory
T cells in vitro (Fig. 5 A), confirming the immature state of
the TNF- –treated LC-type cells. In contrast, monocyte-
derived DCi generated in the absence of TGF- 1 became
Figure 5. LC-type DCs cultured with TNF-  ex-
press CCR7 and migrate toward CCR7 ligands but are
not functionally mature. (A) Autologous antigen pre-
sentation. LC-type cells (left) and DCi (right) unstimu-
lated (open circles), or treated with TNF-  (closed cir-
cles) or CD40-activated LCs (closed triangles) were
pulsed with TT. T cell proliferation was measured as
indicated in Materials and Methods. Results are ex-
pressed as mean of triplicates in a representative experi-
ment. SD were  20%. (B) Both SLC and ELC trigger
migration of TNF-  and E. coli treated, but not control unstimulated LC-type cells. Day 6, LCs were treated for 48 h with TNF-  (10 ng/ml) or with
heat-inactivated E. coli (50:1 ratio, right). Then, samples were recovered and cells were tested for their capacity to migrate in response to ELC (100 ng/
ml) and to SLC (100 ng/ml). Migration assays were performed in Boyden microchambers. (Left) Results are expressed as number of migrating LCs per
two low power fields (original magnification:  20). (Right) Results are expressed as migration index compared with medium alone (without chemo-
kine). Results are representative of more than three independent experiments. (C) CCR7 expression. Day 6, LC-type and DC-type cells were treated for
48 h with 10 ng/ml TNF- . Cells were washed and stained with PE-conjugated anti-Langerin, FITC-anti-DR and anti-CCR7 or with isotype-matched
controls antibodies and analyzed by flow cytometry. In the left panel, the dot-plot represent langerin and HLA-DR expression of LC-type cells treated
with TNF- . On the center and right panels histograms represent CCR7 expression on gated-cell populations (R1:Langerin1 DRlo; R2: Langerin-,
DRhi). Thick lines represent the labeling obtained with CCR7 antibody and thin lines represent labeling with the isotype-matched control. Results are
representative of two independent experiments.425 Geissmann et al.
mature after exposure to TNF-  and thereafter, efficiently
stimulated autologous antigen specific T cells (Fig. 5 A).
On the other hand, the presence of immature LCs
within the afferent sinuses in DL LNs suggests that imma-
ture LCs are able to migrate toward the LNs. This migra-
tion has been shown to involve downregulation of E-cad-
herin expression (50), and acquisition of the chemokine
receptor CCR7 allowing migration in response to the che-
Figure 6. LPS and bacteria in-
duce the maturation of DCi but
not LC-type cells. Interstitial-
type and LC-type DC were cul-
tured for 5–6 d as indicated in
Materials and Methods and incu-
bated with either LPS, heat-inac-
tivated E. coli, or BCG-GFP. (A
and B) Coculture with LPS in-
duces the maturation of intersti-
tial type, but not LC-type DCs.
LC-type (A) and (B) DCi treated
with LPS were fixed, permeabi-
lized, stained with FITC-conju-
gated anti–HLA-DR antibody
and anti-Langerin antibody re-
vealed with anti–mouse Cy3 (in
red), and analyzed by confocal
microscopy. Original magnifica-
tion:   400. (C–E) Coculture
with heat inactivated E. coli does
not induce the maturation of
LC-type DC. LC-type DCs
were cultured for 40 h in the
presence of Texas-red conju-
gated heat-inactivated E. coli at a
50/1 ratio (C-E) or LcCD40L
(F) and then collected, washed,
fixed, permeabilized and stained
with either FITC-conjugated
anti-Langerin antibody (C and
D) or FITC-conjugated anti–
HLA-DR antibody and anti-
Langerin antibody revealed with
anti–mouse Cy5 (in blue) (E and
F), and analyzed by confocal mi-
croscopy. Coculture of DCi in-
duced their maturation (unpub-
lished data). Panel G LC-type
DC were cultured for 36 h in the
presence of BCG-GFP and then
collected, washed, fixed, perme-
abilized, stained with PE-conju-
gated anti-HLA-DR antibody
and anti-Langerin antibody re-
vealed with anti mouse Cy5 (in
blue), and analyzed by confocal
microscopy. Arrow indicates a
Langerin  DRhi DC and arrow-
heads Langerin  DRlo DCs. Co-
culture of DCi with BCG-GFP
induced their maturation (un-
published data). Bar   10  m,
unless otherwise indicated.426 Differentiation of Langerhans Cells in Response to Inflammation
mokines SLC (CCL19) and ELC (CCL21) (16–20). We
have previously shown that TNF-  downregulates E-cad-
herin expression on immature LC-type cells (21). There-
fore, we evaluated the chemotactic activity of the CCR7
ligands, SLC (CCL21) and ELC (CCL19) on the mono-
cyte-derived LCs. Both chemokines remarkably induced
the migration of TNF- –treated, but not control LC-type
cells generated in the absence of TNF-  (Fig. 5 B). In ac-
cordance with this finding, TNF-  increased the amounts
of CCR7 mRNA by 32–64-fold as evaluated by real-time
quantitative PCR (unpublished data). To rule out that the
expression of CCR7 was due to the small fraction of ma-
ture LC-type cells present in the cultures, we then studied
the expression of CCR7 on TNF- –treated MHC class
IILo LC-type cells (Fig. 5 C). A high percentage (64%) of
“immature” MHC class IILo cells expressed high levels of
CCR7. Altogether, these data indicate that, even in the ab-
sence of maturation, TGF- 1 and TNF-  can induce the
chemotactic machinery required for the emigration of LCs
toward the draining LNs.
Bacterial Products also Induce Langerin Expression, Mainte-
nance of an Immature LC Phenotype and Migration toward
CCR7 Ligands. We further investigated the effects of ex-
posure to bacterial products, likely to occur in an inflam-
matory skin, mucosa, or lung, on the maturation of mono-
cyte-derived LCs. Exposure to LPS was found to induce
Langerin expression on LC-type DCs (Fig. 6 A). This in-
duction resulted in a twofold increase in Langerin  cells
(from 28 to 52% of cells as counted on wide-field micro-
graphs) but LPS induced neither DC–LAMP expression,
nor the translocation of MHC class II molecules to the cell
surface (Fig. 6 A). In contrast to LC-type cells, LPS in-
duced the maturation of DCi used as controls without sig-
nificant induction of Langerin expression (Fig. 6 B).
We speculated that, in contrast to purified LPS, whole
bacteria corpses might promote both the recruitment and
the maturation of LCs. Therefore, we cultured LC-type
cells for up to 40 h in presence of heat-inactivated E. coli–
conjugated to Texas-red (at a 50:1 bacteria to cell ratio).
Exposure to E. coli led to an increase in both the percent-
age of Langerin-positive cells (from 28 to 58% as counted
on Fig. 6 C), and the intensity of Langerin staining (data
not shown). Interestingly, most of the Langerin  cells in-
teracted with bacteria on their cell surface (Fig. 6 D),
whereas Langerin-negative cells internalized the bacterial
corpses. MHC class II staining remained mostly intracellu-
lar and typical of immature DCs in these cells (Fig. 6 E).
Analogous to TNF-  treatment, the exposure to E. coli
triggered also the migration of LC-type cells toward CCR7
ligands (Fig. 5 B). In contrast to LCs cultured in the pres-
ence of heat-inactivated E. coli alone, subsequent exposure
to CD40L induced LC maturation with a typical MHC
class II surface staining and intracellular langerin staining
(Fig. 6 F). Unlike LCs, DCi cultured with heat-inactivated
E. coli rapidly and fully matured as assessed by translocation
of MHC class II to the cell surface and DC–LAMP expres-
sion (unpublished data).
Finally, we wished to determine whether exposure to
live bacteria would necessarily induces LC maturation in
vitro. For this purpose, we used the slow growing live My-
cobacterium bovis (BCG) expressing the (BCG-GFP), instead
of the impractical rapidly-dividing E. coli. As shown in Fig.
6 G, most Langerin  LCs also remained immature after
culture in the presence of GFP-BCG expressing intracellu-
lar MHC class II, although they bound mycobacteria.
These data demonstrate that in vitro cultured LC-type cells
remain in an immature state despite exposure to live bacte-
ria. Taken together, our results show that TGF- 1 cooper-
ates with a wide range of inflammatory stimuli-including
TNF- , LPS, and bacteria- likely to be encountered in in-
flammatory skin as well as in mucosae and lung to promote
the differentiation of LCs, which exhibit an immature phe-
notype but are prone to migrate to draining LNs.
Discussion
Our study addressed the question of the regulation of LC
maturation in response to inflammation in vivo and in
vitro. We show here an expanded population of immature
LCs in skin draining LNs of DL patients. The Langerin 
CD1a  E-cadherin  cells observed in the T cell areas of
DL LNs are likely to derive from skin LCs, as suggested by
their presence in the afferent sinuses. Nevertheless, there is
no formal direct proof that they do not derive from other
(e.g., circulating) precursors. However, irrespective of their
origin, our data demonstrate that recruitment to the LNs
and maturation of LCs can be dissociated in response to in-
flammatory signals in vivo.
Although surprising, our observations in DL LNs are
consistent with several other observations. Takahashi et al.
have observed that the majority of the very rare CD1a 
DCs present in peripheral human LNs, express neither
CD86 nor CD83 and poorly stimulate alloreactive T cells,
but are able to mature after in vitro culture (51). We have
reported that even in inflammatory condition, CD1a 
CD83  cells are numerous in the draining LNs (21). More
recently, Ruedl et al. have shown that mouse DCs that
have emigrated from the skin into the LNs after cutaneous
challenge with acetone, dibutyl-phtalate, and LPS, are still
able to internalize and process antigen (52) a property asso-
ciated with immature DCs. Finally, LCs recovered from
various tissues in patients with LC histiocytosis, a pediatric
disease characterized by the accumulation of LCs in lym-
phoid and nonlymphoid tissues, are phenotypically and
functionally immature, although able to mature in vitro in
response to CD40 ligation (53).
As an in vitro model of LC mobilization in response to
proinflammatory mediators, we studied the effects of in-
flammatory stimuli such as TNF-  and bacterial products
on the functional activation of LCs differentiated from
monocyte cultures in the presence of TGF- 1. We found
that such monocyte derived LC-type cells can be stimu-
lated by proinflammatory signals and (a) express high lev-
els of Langerin which upon cross-linking is internalized
into BGs, (b) express CCR7 and accordingly acquired the
migration properties in response to LN chemoattractant427 Geissmann et al.
CCR7 ligands, and (c) do not acquire a mature phenotype
(i.e., do not express CD86, DC–LAMP, are membrane
MHC class IIlo, and do not stimulate T cells efficiently).
This immature stage is presumably reinforced by the pres-
ence of TGF- 1. Of note, the  v 6 integrin binds and
activates latent TGF- 1, produced by epithelial cells such
as keratinocytes, a mechanism triggered by inflammation
(54). Based on these data, one can hypothesize that, in
vivo, TGF- 1 may synergize with inflammatory stimuli
such as TNF-  to enhance the differentiation of LCs from
their precursors, antigen uptake via Langerin expression,
and emigration of these LCs in an immature state to the
draining LNs due to CCR7 expression. Further studies
are however required to delineate the molecular mecha-
nisms, which could differentially trigger LC migration and
LC maturation.
CD40L, TNF- , LPS, and bacteria induce the matura-
tion of monocyte-derived DCi, while only CD40L in-
duced the maturation of LCs cultured from the same
monocytes in the presence of TGF- 1. Dissection of the
effect of TGF- 1 on the cellular activation pathways
downstream to CD40 and TNF-R, and on the regulation
of chemokine-receptors expression and function may help
to clarify the molecular basis for the split control of LC
migration and LC maturation in response to inflammatory
stimuli, as well as their differential effects on DCi and LCs.
In this study, we formally identified Langerin  LCs and
characterized their maturation stage during an ongoing
physiologic chronic cutaneous inflammatory process. It is
remarkable that immature LCs represent the majority of
DCs in LNs draining these chronic lesions of various etiol-
ogies. This suggests that, at a given time, lymphocytes in T
cell areas of DL LNs may mostly encounter immature LCs,
whether or not individual LCs will ultimately become ma-
ture. Indeed, the fact that LCs recruited to the T cell areas
of the draining LNs exhibit a typical immature phenotype,
raises questions about the regulation of LC maturation,
and importantly about the role of LCs in the regulation of
immune responses since immature DCs have been pro-
posed to mediate tolerance (1, 2, 22–25) (for a review, see
reference 26).
The physiologic function of DCs in the steady-state in
vivo has only begun to be determined. Recently, DCs have
been shown to induce tolerance in vivo (22–25). Current
evidence thus suggests that DCs that migrate constitutively
from peripheral tissues in the absence of any overt antigenic
or inflammatory stimuli (25, 55) do not mature and may
mediate tolerance, while DCs that migrate as a result of in-
flammatory stimuli undergo maturation, due to the inflam-
matory signal, and therefore would trigger an immune re-
sponse. It is still difficult to understand how autoimmune
responses are avoided in inflammatory conditions. Based on
our results we would like to hypothetize that, in contrast to
DCi, migrating immature LCs most likely cannot deliver
an activation signal to antigen-specific T cells and may
therefore induce tolerance. It is conceivable that the re-
cruitment of immature LCs to LNs in response to skin or
mucosal inflammation might be a mechanism to prevent
immunization against the self (epithelium) in inflammatory
conditions, when abundant cell death may lead to the pre-
sentation of self-antigens. DCs efficiently carry out the ex-
ogenous pathway for MHC class I presentation (56–59)
and immature LCs could therefore directly be involved in
the maintenance of T cell peripheral tolerance because of a
lack of costimulatory molecules. Alternatively, tolerance to
self antigens needs not be direct, and immature LCs, upon
reaching the LN, might transfer tissue-derived peptides to a
subset of bystander DCs somehow specialized in tolerance,
although direct evidence for this DCs subset remains elu-
sive (25, 60). Another possibility, as stated above, is the re-
cruitment of LC-precursor from the blood through HEV
directly in the LN draining inflamed skin. In this case,
“blood-derived LCs” could also directly be involved in the
uptake of self-antigens and the maintainance of T cell pe-
ripheral tolerance.
The function of LN LCs could not be directly assessed
here. However, patients with DL do not present skin de-
pigmentation (vitiligo) or other skin autoimmune disease.
This indicates that despite the likely presence of epithelial
antigens in the LNs (melanin could be detected in some
LN LCs in our study, unpublished data) the immune re-
sponse does not lead to the recruitment or activation of cy-
totoxic anti-self effector T cells in the skin.
However, LCs may also display other functions within
the LNs. They may store, or even acquire, antigen inside
the T cell areas. LCs would probably also be prone to
eventually undergo maturation within the T cell areas in
response to further signals such as CD40L. The lack of a
potent effect of bacteria on LC maturation in vitro does
not rule out the activation of LCs in vivo in some circum-
stances, for example through T cell help due to CD40L 
T cells that would recognize bacterial antigens presented
by LCs. Therefore, LCs may be both involved in periph-
eral tolerance and the initiation of specific immune re-
sponse. Although these questions cannot be addressed
here, it will be of interest to determine the respective role
and fate of immature LCs and of DCi within LNs. Condi-
tional cell depletion, and cell-type specific knock-out ex-
periments in mouse models will be useful to explore these
points.
Finally, we do not know if the mature CD83 
Langerin  DCs that also enter the afferent sinuses of DL
LNs may correspond either to DCi or to mature LCs that
would have lost Langerin expression. However, since (a)
the CD83  DCs can be seen in the afferent sinuses (Fig. 1),
and (b) Langerin expression persisted at high levels in intra-
cellular compartments after in vitro maturation (at least for
48 h, Fig. 3 C, and reference 30), and (c) since DCi are pe-
culiar by their quick differentiation from circulating mono-
cytes and maturation upon inflammatory stimuli in vivo
(44), the mature DCs observed in the LN sinuses are more
likely to represent DCi rather than LCs. Monocyte-derived
DCi cultured in the absence of TGF- 1 mature in vitro in
response to inflammatory stimuli. It is possible that the
Langerin  DCs that are observed in the sinuses and T cell
areas of inflamed LNs represent the in vivo equivalent to428 Differentiation of Langerhans Cells in Response to Inflammation
monocyte-derived DCi, emphasizing the heterogeneity of
DC subsets.
In conclusion, we have shown here that inflammatory
and bacterial stimuli contribute to the differentiation of im-
mature LCs by upregulating Langerin expression in vitro,
and allow their recruitment as immature DCs into the T
cell areas of LNs in vivo. LCs may transport self-antigens,
and possibly pathogens, to the lymphoid organs and then,
depending on further signals received in the LN, either
contribute to tolerance, or after maturation, initiate a pro-
ductive immune response.
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